Rare Diseases Global Market Report 2024-2034: Robust Pipeline by Major Players and Increasing Number of Drug Approvals
July 02, 2024 04:01 ET
|
Research and Markets
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "Rare Diseases Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Rare Diseases Market is forecast to...
Gene Therapy For Ocular Rare Disease Pipeline Insight Report 2024
April 25, 2024 04:06 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides...
Rare Disease Treatment Market to Achieve USD 228.34 Billion by 2028, Showcasing a Compound Annual Growth Rate of 11.08%
February 02, 2024 10:52 ET
|
Research and Markets
Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Rare Disease Treatment Market (2023-2028) by Therapeutic Area, Drug Type, Drug Class, Mode of Administration, Distribution Channel, and...
Emerging Trends in the Orphan Drugs Industry, 2023-2028: Worldwide Market Analysis Featuring Profiles of Leading Players AstraZeneca, Eisai, Bristol Myers Squibb, and Pfizer Among Others
January 17, 2024 10:03 ET
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Orphan Drugs" report has been added to ResearchAndMarkets.com's offering. The global orphan drugs market was valued at an...
Global Orphan Drugs Market Research Report 2023
September 19, 2023 05:38 ET
|
Research and Markets
Dublin, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The "Orphan Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global orphan drugs market is expected to grow...
Rare Diseases Treatment Market to Rise High at US$346.5 Bn by 2029 End, Projects Fairfield Market Research
October 03, 2022 09:33 ET
|
Fairfield Consultancy Services OPC Pvt Ltd
London, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Projected to exhibit robust 10.4% growth between 2022 and 2029, global rare diseases treatment market will possibly reach the revenue of around US$346.5 Bn...